Target Information
Danish company Demant is one of the world's leading manufacturers of hearing aids, holding a global market share of over 20 percent. The business operates on three main fronts: hearing aids account for 45 percent of revenue, the Audika hearing clinic sector represents 40 percent with over 4,000 clinics worldwide, and the diagnostics segment contributes 11 percent.
The global hearing aid market is valued at approximately $7 billion, with Demant estimating an annual growth rate of around 4 to 6 percent. Key drivers of this growth include an aging population and an increasing adoption rate of hearing aids.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The hearing aid industry exhibits a cyclical pattern, transitioning through five-year intervals of market demand influenced by health reimbursement policies in various countries. This fluctuation reflects market dynamics; for inst
Similar Deals
athagoras → DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH
2025
Demant
invested in
KIND
in 2026
in a Other deal
Disclosed details
Transaction Size: $748M
Revenue: $317M